News Releases

Jul. 01, 2015 Print(PDF/57KB)Corporate

Sumitomo Dainippon Pharma announces Changes in Executive Officers and Other Key Positions

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada) today announced that the following changes in Executive Officers and other key positions will take place effective August 1, 2015:

I. Changes in Executive Officers

Changes in the posts assumed by Executive Officers (effective August 1, 2015)
Post as of August 1, 2015Current postName
Representative Director, President and Chief Executive Officer
Executive Director, Drug Development		 Representative Director, President and Chief Executive Officer Masayo Tada
Executive Officer
Deputy Executive Director, Drug
Development		 Executive Officer
Executive Director, Drug Development		 Nobuyuki Hara

II. Changes in Personnel (effective August 1, 2015)

Drug Development (Division)
Position as of August 1, 2015Current positionName
Director, Project Management Senior Advisor, Drug Development Teruya Murata
Director, Data Science Deputy Executive Director, Drug Development
Director, Project Management		 Hideo Tomiya
Director, Clinical Operation Group Manager, Clinical Pharmacology Group, Clinical Research Kenji Shirakura